Speakers > Dr. Ahmed Galal

 

Dr. Ahmed Galal

Ahmed Galal is currently a Professor of Medicine at Duke University, School of Medicine, a staff member in the Division of Malignant hematology and Cell Therapy, and the director of the CAR-T program at Duke Cancer Center.

He moved from the Avera Cancer Institute and Bone Marrow Transplant Program, after serving a period of five years as an Associate Professor of Medicine at the Sanford School of Medicine. He served as a Professor of Medicine, Provincial Leader for the Hematology Program, and the Director of the Stem Cell Transplant Program in Saskatchewan from 2010-2011. He joined the Division of Hematology at McGill University and was appointed as the Director of the Stem Cell Transplant Program From 2003-2008. Then, he joined Princess Margaret Hospital, University of Toronto, as a Director of the Allogeneic Stem Cell Transplant Program.

He received his MD in 1987 from Ain Shams University, Cairo, Egypt. He obtained his Master of Clinical Pharmacology in 1993, from Universite de Montreal. He completed his training and certification in Hematological Pathology at Dalhousie University, Halifax, 1993-1997, Internal Medicine at Dalhousie University, Halifax, 1997-1999, Clinical Hematology at University of Western Ontario, London, 1999-2001, and Stem Cell Transplant Fellowship at University of Toronto, Toronto, 2001-2003.

Currently, Dr. Galal’s research is focused on Non-Hodgkin’s Lymphoma with a special interest in CAR-T therapy.

He is currently a member of the Executive Committee of the Canadian Bone Marrow Transplant Group and he was the Chairman of the 2008 Biennial Conference Committee. He is the principle investigator on national and international numerous clinical trials.

He will be speaking on the principle of CAR-T therapy in malignant hematology with emphasis on acute lymphoblastic leukemia and NHL. He will summarize the most recent experience on this modality and discuss its future directions. He will share cases from Duke University as an example of the current practice.